Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma

ClinicalTrials.gov ID: NCT06676319

Public ClinicalTrials.gov record NCT06676319. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 7:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Phase 2, Double-blind, Placebo-controlled, Parallel-group, 2-arm Study to Investigate the Efficacy, Safety, and Tolerability of Subcutaneous Lunsekimig (SAR443765) in Adult Participants With High-risk Asthma Who Are Not Currently Eligible for Biologic Treatment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma. The purpose of this study is to assess the efficacy, safety, and tolerability of add-on therapy with subcutaneous (SC) lunsekimig compared with placebo in male and female participants (aged 18 to 80 years, inclusive) with asthma, who are not currently eligible for biologic treatments. Study details include: * The study duration will be approximately 64 weeks for participants not transitioning into the LTS study and approximately 60 weeks for participants transitioning into the LTS study. * The investigational treatment duration will be up to approximately 52 weeks. * The number of visits will be 18.

Study identification

NCT ID
NCT06676319
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sanofi
Industry
Enrollment
556 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 7, 2024 (Actual)
Primary completion
Jun 21, 2027 (Estimated)
Completion
Jul 19, 2027 (Estimated)
Last update posted
Sep 22, 2026

2024 – 2027

United States locations

U.S. sites
53
U.S. states
20
U.S. cities
50
Facility City State ZIP Site status
The Center for Clinical Trials - Saraland- Site Number : 8400096 Saraland Alabama 36571 —
Chandler Clinical Research Trials- Site Number : 8400075 Chandler Arizona 85224 —
Epic Medical Research - Sun City- Site Number : 8400052 Sun City Arizona 85351 —
Tucson Clinical Research Institute- Site Number : 8400085 Tucson Arizona 85712 —
Ark Clinical Research- Site Number : 8400097 Long Beach California 90815 —
Downtown L.A. Research Center- Site Number : 8400080 Los Angeles California 90017 —
Carbon Health - North Hollywood - NoHo West- Site Number : 8400061 North Hollywood California 91606 —
Carbon Health - San Mateo - Hillsdale Mall- Site Number : 8400062 San Mateo California 94403 —
Stanford University Medical Center- Site Number : 8400108 Stanford California 94305 —
Modena Allergy And Asthma- Site Number : 8400068 Torrance California 90505 —
Howard University Hospital- Site Number : 8400107 Washington D.C. District of Columbia 20060 —
Helix Biomedics- Site Number : 8400005 Boynton Beach Florida 33435 —
Beautiful Minds Clinical Research Center- Site Number : 8400019 Cutler Bay Florida 33157 —
Omega Research Consultants - Debary - North Charles Richard Beall Boulevard- Site Number : 8400082 DeBary Florida 32713 —
Alfa Medical Research- Site Number : 8400071 Hollywood Florida 33024 —
Royal Clinical Trials - Inverness- Site Number : 8400067 Inverness Florida 34453 —
Premier Medical Associates- Site Number : 8400077 Lady Lake Florida 32159 —
D&H Pompano Research Center- Site Number : 8400072 Margate Florida 33063 —
Research Institute of South Florida- Site Number : 8400023 Miami Florida 33173 —
Innovations Biotech- Site Number : 8400044 Miami Florida 33186 —
Tellabio International Research Services- Site Number : 8400083 Pembroke Pines Florida 33025 —
Avanza Medical Research Center- Site Number : 8400056 Pensacola Florida 32503 —
Ilumina Medical Research- Site Number : 8400095 Saint Cloud Florida 34769 —
Private Practice - Dr. David Kavtaradze- Site Number : 8400081 Cordele Georgia 31015 —
EmVenio Research - Riverdale- Site Number : 8400109 Riverdale Georgia 30274 —
Christie Clinic in Champaign on University- Site Number : 8400003 Champaign Illinois 61820 —
University of Kansas Medical Center- Site Number : 8400105 Kansas City Kansas 66160 —
Velocity Clinical Research - Rockville (formerly Meridian Clinical Research)- Site Number : 8400036 Rockville Maryland 20854 —
Javara - Privia Medical Group - Silver Spring Lockwood- Site Number : 8400042 Silver Spring Maryland 20901 —
University of Michigan Health System - Ann Arbor- Site Number : 8400014 Ann Arbor Michigan 48109 —
Clarkston Medical Group- Site Number : 8400054 Clarkston Michigan 48346 —
Javara - Mankato Clinic- Site Number : 8400001 Mankato Minnesota 56001 —
Mayo Clinic in Rochester - Minnesota- Site Number : 8400057 Rochester Minnesota 55905 —
Hannibal Regional Healthcare System- Site Number : 8400078 Hannibal Missouri 63401 —
Icahn School of Medicine at Mount Sinai (ISMMS) - Mount Sinai Doctors- Site Number : 8400069 New York New York 10011 —
Pioneer Clinical Research - New York- Site Number : 8400092 New York New York 10016 —
Piedmont Healthcare - Family Medicine- Site Number : 8400064 Statesville North Carolina 28625 —
Cleveland Clinic - Cleveland- Site Number : 8400106 Cleveland Ohio 44195 —
Asthma & Allergy Center - Toledo- Site Number : 8400020 Toledo Ohio 43617 —
OK Clinical Research- Site Number : 8400060 Edmond Oklahoma 73034 —
Clinical Research Associates of Central Pennsylvania- Site Number : 8400013 DuBois Pennsylvania 15801 —
Thomas Jefferson University Hospital- Site Number : 8400110 Philadelphia Pennsylvania 19107 —
Allergic Disease and Asthma Center (ADAC)- Site Number : 8400070 Greenville South Carolina 29607 —
Orion Clinical Research- Site Number : 8400084 Austin Texas 78759 —
South Texas Medical Research Institute - TTS Research- Site Number : 8400015 Boerne Texas 78006 —
Epic Medical Research - De Soto- Site Number : 8400051 DeSoto Texas 75115 —
Axsendo Clinical Research - Houston- Site Number : 8400065 Houston Texas 77058 —
Metroplex Pulmonary and Sleep Center- Site Number : 8400012 McKinney Texas 75069 —
STAAMP Research - San Antonio- Site Number : 8400059 San Antonio Texas 78229 —
Bandera Family Health Care - San Antonio- Site Number : 8400049 San Antonio Texas 78249 —
Javara - San Marcos - Redwood Road- Site Number : 8400040 San Marcos Texas 78666 —
Simcare Medical Research- Site Number : 8400102 Sugar Land Texas 77478 —
Children's Wisconsin- Site Number : 8400073 Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 168 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06676319, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 22, 2026 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06676319 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →